IAN0982-VHH25

N/A

Report date: 2024/04/01 16:03:56

Base Information

Drug NameIAN0982-VHH25

Drug Alias NameIAN0982-VHH25

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-CD276Natural killer cell p30-related protein binders

TargetsCD276 antigenNatural killer cell p30-related protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSunHo (China) BioPharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesSunHo (China) BioPharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A